Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?

M. Mazzotta, M. Barba, L. Pizzuti, P. Vici

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)S1281-S1284
JournalTranslational Cancer Research
Volume6
Issue numberS7
Publication statusPublished - 2017

Cite this

Is there a role for adjuvant pertuzumab in HER2-positive breast cancer? / Mazzotta, M.; Barba, M.; Pizzuti, L.; Vici, P.

In: Translational Cancer Research, Vol. 6, No. S7, 2017, p. S1281-S1284.

Research output: Contribution to journalArticle

Mazzotta, M, Barba, M, Pizzuti, L & Vici, P 2017, 'Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?', Translational Cancer Research, vol. 6, no. S7, pp. S1281-S1284.
Mazzotta, M. ; Barba, M. ; Pizzuti, L. ; Vici, P. / Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?. In: Translational Cancer Research. 2017 ; Vol. 6, No. S7. pp. S1281-S1284.
@article{3af08ed722cf41c0818ba4a5c77a47c2,
title = "Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?",
author = "M. Mazzotta and M. Barba and L. Pizzuti and P. Vici",
year = "2017",
language = "English",
volume = "6",
pages = "S1281--S1284",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",
number = "S7",

}

TY - JOUR

T1 - Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?

AU - Mazzotta, M.

AU - Barba, M.

AU - Pizzuti, L.

AU - Vici, P.

PY - 2017

Y1 - 2017

M3 - Article

VL - 6

SP - S1281-S1284

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

IS - S7

ER -